
|Articles|January 7, 2020
Signant Health Partners with Propeller Health
Advertisement
Signant Health has announced a partnership to connect TrialMax to Propeller Health’s digital health platform for asthma and chronic obstructive pulmonary disease. The partnership will help drive patient adherence to inhaled medications by enabling accurate time tracking of patients’ medication use events alongside their eDiary data within a single electronic Clinical Outcome Assessment platform.
To learn more, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
2
Building Broader Investigator Networks to Advance Global Breast Cancer Research
3
ACT Brief: AI Expands Global Site Leadership as Ozempic Shows Potential to Reverse Biological Age
4
AI Offers New Pathways to Strengthen Site Leadership in Underserved Regions
5






.png)



.png)



.png)
.png)
